Newsroom
Sorted by: Latest
-
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Momentum UCITS ETF 17.06.2026 FTMO.LN IE000CY30YV9 3,050,002.00 USD 94,874,032.83 31.106 ...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust SMID Rising Dividend Achievers UCITS ETF 17.06.2026 SDVI.LN IE000YVOQ2A3 40,361.00 USD 1,148,586.31 28.458 ...
-
Top Summer Destinations 2026 Revealed by Leading Travel Agent Opodo
LONDON--(BUSINESS WIRE)--Leading online travel agent Opodo (part of eDreams ODIGEO) launches its 2026 summer travel report, uncovering British traveller’s top destinations – and also diving deep into travel patterns for July and August compared to last year. Want to check out the full summer report? See Opodo’s latest blog post here. Top summer city destinations booked by Brits Opodo’s report reveals that Brits are most keen on short haul sunny breaks this summer. The OTA’s data shows that thes...
-
Channel Bans Reach Four-Year High as Financial Services Firms Reassess Communications Compliance Strategies, New Global Relay Report Finds
NEW YORK--(BUSINESS WIRE)--Global Relay, a leading provider of digital communications governance and archiving solutions for global financial services and other highly regulated industries, today shared the findings of its Industry Insights Report 2026, which examines how compliance professionals in financial services are navigating communications governance, AI adoption, and evolving regulatory expectations. The report found 66% of financial services firms now ban communications channels, the...
-
Un nouveau pèlerinage de la Sainte Famille, lancé pour aider les croyants à se préparer pour le 2000e anniversaire de la mort et résurrection de Jésus-Christ en 2033, met en lumière l’histoire catholique le long du Saint-Laurent
OTTAWA, Ontario--(BUSINESS WIRE)--La Sainte Famille prendra vie d’une manière nouvelle et immersive avec le lancement, en septembre 2027, du pèlerinage de la Sainte Famille. Ce pèlerinage débutera lors du Forum panaméricain de la Confédération (PAC27), un forum intercontinental qui marque le coup d’envoi de la « Route vers le Forum mondial de 2033 » à Rome. Le pèlerinage de la Sainte Famille propose un parcours de six jours à la découverte du riche héritage catholique du Canada. Au programme :...
-
New Holy Family Pilgrimage Experience unveils Catholic history along the St. Lawrence Seaway, launches at once-in-a-millennium PAC27 intercontinental forum
OTTAWA, Ontario--(BUSINESS WIRE)--The Holy Family will come alive in a new and experiential way with the September 2027 launch of The Holy Family Pilgrimage Experience. The pilgrimage launches at the Pan American Confraternity Forum (PAC27), a once-in-a-millennium intercontinental forum that kicks off the Road to the 2033 World Forum in Rome. The Holy Family Pilgrimage Experience offers a six-day behind-the-scenes look at Canada’s rich Catholic legacy. Included are pilgrimages to basilicas devo...
-
Portal Biotechnologies Accelerates Growth with Latest Round Led by NFX, Expanded DARPA Contract, and Broad Adoption Across Top Pharma and Academic Centers
WATERTOWN, Mass.--(BUSINESS WIRE)--Today, Portal Biotechnologies, Inc. (“Portal”), a cell engineering and drug discovery platform company, announced updates on significant commercial progress and the closing of an oversubscribed $9M financing round led by NFX and participation from existing investors including IA Ventures, Pear VC, Undeterred Ventures, IKJ Capital, and TechU Ventures. Portal is building the universal infrastructure for cell engineering across drug discovery and cell therapy. Th...
-
Arrowhead Pharmaceuticals to Host a Webinar on its Cardiometabolic Pipeline as Part I of the 2026 Summer Series of R&D Webinars
PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced its plan to host a 2026 Summer Series of R&D webinars that highlight multiple clinical stage RNA interference (RNAi) based medicines that utilize the company’s proprietary Targeted RNAi Molecule (TRiM™) platform. Each webinar in the Summer Series will focus on a specific therapeutic area and will feature presentations by Arrowhead team members about the company’s clinical candidates and externa...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Alerian Disruptive Technology Real Estate UCITS ETF 17.06.2026 LANDXEN.LN IE000C75IMX8 15,878.00 USD 313,516.03 19.745 ...